Unraveling the Spatiotemporal Distribution of VPS13A in the Mouse Brain

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Loss-of-function mutations in the vacuolar protein sorting 13 homolog A (VPS13A) gene cause Chorea-acanthocytosis (ChAc).
• The neuropathological hallmark of ChAc is selective striatal degeneration.
• VPS13A expression patterns in the brain remain largely uncharacterized.

Purpose of the Study:

• To determine the spatiotemporal distribution of VPS13A expression in the mouse brain.
• To investigate VPS13A localization within different neuronal subtypes and cellular compartments.
• To assess the stability of VPS13A expression under pharmacological modulation.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) for VPS13A mRNA.
• Western blotting and immunohistochemistry for VPS13A protein.
• Cellular and subcellular localization studies using co-localization experiments.
• Pharmacological manipulation of neurotransmitter systems.

Main Results:

• VPS13A expression is detected in neurons during embryonic development and remains stable into adulthood.
• Widespread VPS13A distribution observed across the brain, with highest levels in the pons, hippocampus, and cerebellum, and low levels in the basal ganglia.
• VPS13A localizes to neuronal soma and neurites, co-localizing with endoplasmic reticulum and mitochondria, but not enriched in dendritic spines or synaptosomes.
• Pharmacological modulation of glutamatergic, dopaminergic, or cholinergic systems did not alter VPS13A levels in key brain regions.

Conclusions:

• VPS13A exhibits stable expression in neuronal cells throughout development and adulthood.
• The distinct expression profile of VPS13A provides insights into the pathophysiology of Chorea-acanthocytosis.
• Further research into VPS13A function is warranted to understand its role in neuronal health and disease.